Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4640

BillFederalSenateIn Committee
A bill to amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders, which shall also satisfy certain training requirements to receive a waiver for dispensing narcotic drugs for maintenance or detoxification treatment, and for other purposes.
About This Bill
Committee
Latest Action · September 22, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
September 22, 2020
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Medication Access and Training Expansion Act of 2020 or the MATE Act of 2020 This bill requires prescribers of controlled substances, as a condition of obtaining or renewing their registration with the Drug Enforcement Administration, to complete specified education or training on the prevention, treatment, and management of opioid-use and other substance-use disorders. This education and training shall also satisfy the training requirements currently needed to obtain waivers to prescribe certain medication-assisted treatments for opioid-use disorders in settings other than opioid treatment programs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.